Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Greg Siller

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
The Australasian Journal of Dermatology|July 27, 2006
Use of 5% imiquimod cream in the treatment of facial basal cell carcinoma: a 3-year retrospective follow-up studyYin Vun, Greg Siller
The Australasian Journal of Dermatology|February 14, 2004
Psoriasis induced by topical imiquimodJason K Wu, Greg Siller, Geoff Strutton
The Australasian Journal of Dermatology|May 20, 2003
Treatment of Bowen's disease and basal cell carcinoma of the nose with imiquimod 5% creamJason K Wu, Greg Siller, Kevin Whitehead
The Australasian Journal of Dermatology|May 25, 2011
Pigmented spindle cell naevus of Reed: a controversial diagnostic entity in AustraliaScott A Webber, Greg Siller, H Peter Soyer
The Australasian Journal of Dermatology|January 13, 2006
An open-label, pilot study examining the efficacy of curettage followed by imiquimod 5% cream for the treatment of primary nodular basal cell carcinomaJason K Wu, Carol Oh, Geoff Strutton, et al.
The Australasian Journal of Dermatology|January 31, 2009
PEP005 (ingenol mebutate) gel, a novel agent for the treatment of actinic keratosis: results of a randomized, double-blind, vehicle-controlled, multicentre, phase IIa studyGreg Siller, Kurt Gebauer, Peter Welburn, et al.
The Journal of Investigative Dermatology. Symposium Proceedings|April 16, 2004
The effect of skin examination surveys on the incidence of basal cell carcinoma in a Queensland community sample: a 10-year longitudinal studyPatricia Casarolli Valery, Rachel Neale, Gail Williams, et al.
The Australasian Journal of Dermatology|June 16, 2010
PEP005 (ingenol mebutate) gel for the topical treatment of superficial basal cell carcinoma: results of a randomized phase IIa trialGreg Siller, Robert Rosen, Michael Freeman, et al.
Vaccines|January 28, 2026
Booster Immunisation with Skin-Patch-Delivered Unadjuvanted SARS-CoV-2 Spike Protein Vaccine Is Safe and Immunogenic in Healthy AdultsChristopher L D McMillan, David A Muller, Germain J P Fernando, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
The Australasian Journal of Dermatology|July 27, 2006
Use of 5% imiquimod cream in the treatment of facial basal cell carcinoma: a 3-year retrospective follow-up studyYin Vun, Greg Siller
The Australasian Journal of Dermatology|February 14, 2004
Psoriasis induced by topical imiquimodJason K Wu, Greg Siller, Geoff Strutton
The Australasian Journal of Dermatology|May 20, 2003
Treatment of Bowen's disease and basal cell carcinoma of the nose with imiquimod 5% creamJason K Wu, Greg Siller, Kevin Whitehead
The Australasian Journal of Dermatology|May 25, 2011
Pigmented spindle cell naevus of Reed: a controversial diagnostic entity in AustraliaScott A Webber, Greg Siller, H Peter Soyer
The Australasian Journal of Dermatology|January 13, 2006
An open-label, pilot study examining the efficacy of curettage followed by imiquimod 5% cream for the treatment of primary nodular basal cell carcinomaJason K Wu, Carol Oh, Geoff Strutton, et al.
The Australasian Journal of Dermatology|January 31, 2009
PEP005 (ingenol mebutate) gel, a novel agent for the treatment of actinic keratosis: results of a randomized, double-blind, vehicle-controlled, multicentre, phase IIa studyGreg Siller, Kurt Gebauer, Peter Welburn, et al.
The Journal of Investigative Dermatology. Symposium Proceedings|April 16, 2004
The effect of skin examination surveys on the incidence of basal cell carcinoma in a Queensland community sample: a 10-year longitudinal studyPatricia Casarolli Valery, Rachel Neale, Gail Williams, et al.
The Australasian Journal of Dermatology|June 16, 2010
PEP005 (ingenol mebutate) gel for the topical treatment of superficial basal cell carcinoma: results of a randomized phase IIa trialGreg Siller, Robert Rosen, Michael Freeman, et al.
Vaccines|January 28, 2026
Booster Immunisation with Skin-Patch-Delivered Unadjuvanted SARS-CoV-2 Spike Protein Vaccine Is Safe and Immunogenic in Healthy AdultsChristopher L D McMillan, David A Muller, Germain J P Fernando, et al.
Pageof 1